 |

Use Limits to Add Precision?
TOPIC: In MEDLINE® (File 154) and EMBASE® (File72) descriptors representing the main emphasis of the article are major descriptors and are designated by an asterisk (*) in front of the descriptor. The /DE* and /DF* suffixes can be used to restrict retrieval to records in which the specified term is a major MeSH descriptor. Alternatively, the /MAJ suffix can be used to limit retrieval to major descriptors. The remaining descriptors are minor descriptors, which are included in the search when the asterisk is not used and are displayed in a record without asterisks.
In addition, MEDLINE, EMBASE and BIOSIS Previews® (File 55) provide Limits that allow searchers to restrict retrieval to human subjects in English language articles. See Command Summaries for EMBASE and BIOSIS Previews below.
For more details on descriptors in MEDLINE click here.
For additional details on descriptors in EMBASE click here.
In this example, you will search MEDLINE for adverse effects of oxycodone as a major topic in English language articles about human subjects.
| EMBASE |
BIOSIS Previews |
BEGIN 72
SELECT OXYCODONE/MAJ (L) (AE OR TO OR IT)
SELECT S1/ENG,HUMAN
TYPE S2/8/1-3
TYPE S2/7/1 |
BEGIN 55
SELECT OXYCODONE/DE
SELECT ADVERSE(W) EFFECT? OR POISON? OR TOXIC? OR CONTRAINDICA? OR SIDE(W)EFFECT? OR UNTOWARD OR ADVERSE (W)REACTION?
SELECT S1 AND S2
SELECT S3/ENG,HUMAN
TYPE S4/8/1-3
TYPE S4/7/1 |
COMMAND SUMMARY
BEGIN 154
SELECT OXYCODONE/MAJ(L)(AE OR TO OR PO OR CT)
SELECT S1/ENG,HUMAN
TYPE S2/8/1-3
TYPE S2/7/3
HOW TO...

1. BEGIN File 154 to search MEDLINE.
2. SELECT a descriptor term restricting to /MAJ and Link (L) to desired allowable subheadings.
This example shows oxycodone linked to adverse effects, toxicity, poisoning or contraindications.
3. SELECT Set 1 (S1) restricting results to English language articles and human subjects.
|

?b 154
File 154:MEDLINE(R) 1990-2007/Mar 15
(c) format only 2007 Dialog
Set Items Description
--- ----- -----------
?s oxycodone/maj (L) (ae or to or po or ct)
334 OXYCODONE/MAJ
588348 AE/DE
224688 TO/DE
20007 PO/DE
11452 CT/DE
S1 55 OXYCODONE/MAJ (L) (AE OR TO OR PO OR CT)
?s s1/eng,human
S2 53 S1/ENG,HUMAN |

4. TYPE a few records in Format 8 to see titles, descriptors and publication years.
To select the appropriate record number, look at the range of records in the TYPE command (e.g., 1/8/1-3).
|
?t s2/8/1-3
2/8/1
DIALOG(R)File 154: MEDLINE(R)
(c) format only 2007 Dialog. All rights reserved.
21800529 PMID: 16987359
Assessing cognition and psychomotor function under long-term
treatment with controlled release oxycodone in non-cancer
pain patients.
Jul 2006
Tags: Female; Male
Descriptors: *Analgesics, Opioid--adverse effects--AE;
*Cognition--drug effects--DE; *Oxycodone--adverse effects--AE;
*Psychomotor Performance--drug effects--DE ; Adult; Aged;
Aging--physiology--PH; Analgesics, Opioid--administration and
dosage--AD; Analgesics, Opioid--therapeutic use--TU;
Arousal--drug effects --DE; Attention--drug effects--DE;
Automobile Driving; Delayed-Action Preparations; Endpoint
Determination; Germany; Humans; Middle Aged; Oxycodone--
administration and dosage--AD; Oxycodone--therapeutic use--TU
CAS Registry No.: 0 (Analgesics, Opioid); 0 (Delayed-Action
Preparations); 76-42-6 (Oxycodone)
2/8/2
DIALOG(R)File 154: MEDLINE(R)
(c) format only 2007 Dialog. All rights reserved.
21692807 PMID: 16669750
Medication sleuth: an important role for pharmacists in
determining the etiology of delirium.
Apr 2006
Tags: Female
Descriptors: *Delirium--chemically induced--CI;
*Narcotics--adverse effects--AE; >*Oxycodone--adverse
effects--AE; *Pharmacists; *Substance Withdrawal Syndrome ;
Aged; Delirium--drug therapy--DT; Diagnosis, Differential;
Hospitalization; Humans; Hypnotics and
Sedatives--poisoning--PO; Medical History Taking;
Overdose--therapy--TH; Patient Care Team;
Pyridines--pharmacology--PD; Pyridines--poisoning--PO;
Substance Withdrawal Syndrome--diagnosis--DI
CAS Registry No.: 0 (Hypnotics and Sedatives); 0
(Narcotics); 0 (Pyridines); 76-42-6 (Oxycodone);
82626-48-0 (zolpidem)
2/8/3 DIALOG(R)File 154: MEDLINE(R)
(c) format only 2007 Dialog. All rights reserved.
15920572 PMID: 16368927
Serotonin syndrome induced by fluvoxamine and oxycodone.
Jan 2006
Tags: Female
Descriptors: *Fluvoxamine--adverse effects--AE;
*Oxycodone--adverse effects-- AE; *Serotonin
Syndrome--chemically induced--CI ; Aged; Analgesics,
Opioid--adverse effects--AE; Analgesics, Opioid
--therapeutic use--TU; Depression--drug therapy--DT; Drug
Interactions; Fluvoxamine--therapeutic use--TU; Humans;
Oxycodone--therapeutic use--TU; Pain--drug therapy--DT;
Serotonin Syndrome--physiopathology--PP; Serotonin Uptake
Inhibitors--adverse effects--AE; Serotonin Uptake Inhibitors
--therapeutic use--TU
CAS Registry No.: 0 (Analgesics, Opioid); 0 (Serotonin
Uptake Inhibitors); 54739-18-3 (Fluvoxamine); 76-42-6
(Oxycodone) |

5. TYPE a record(s) you wish to view using Format 7 for the title, bibliographic citation and abstract.
The citation chosen is record 3.
|
?t s2/7/3
2/7/3
DIALOG(R)File 154: MEDLINE(R)
(c) format only 2007 Dialog. All rights reserved.
15920572 PMID: 16368927
Serotonin syndrome induced by fluvoxamine and oxycodone.
Karunatilake Harindra; Buckley Nicholas A
The Canberra Hospital, Canberra, New South Wales,
Australia.
Annals of pharmacotherapy ( United States )
Jan 2006 , 40 (1) p155-7 , ISSN: 1060-0280--Print
Journal Code: 9203131
Publishing Model Print-Electronic
Document type: Case Reports; Journal Article
Languages: ENGLISH
Main Citation Owner: NLM
Record type: MEDLINE; Completed
OBJECTIVE: To report a case of severe serotonergic symptoms
following the addition of oxycodone to fluvoxamine. CASE SUMMARY:
A 70-year-old woman developed severe serotonergic features,
including confusion, nausea, fever, clonus, hyperreflexia,
hypertonia, shivering, and tachycardia, following the addition
of oxycodone 40 mg twice daily to fluvoxamine 200 mg/day, easily
fulfilling diagnostic criteria for serotonin syndrome.
Discontinuation of the offending drugs resulted in resolution
of her symptoms over 48 hours, and no other cause of the
syndrome was identified. Use of the Naranjo probability scale
indicated a probable relationship between the serotonergic
symptoms and the addition of oxycodone to fluvoxamine therapy.
DISCUSSION: Serotonin syndrome is a serious adverse reaction
usually due to interactions with serotonergic drugs. There
have been only 3 previous reports involving oxycodone. Most
previous reports of serotonin syndrome involving analgesics
have been associated with meperidine, dextromethorphan, and
tramadol. Unlike these synthetic opioids, however, oxycodone
does not inhibit the reuptake of serotonin. In addition,
there are a number of other possible pharmacologic mechanisms
for the interaction we observed. CONCLUSIONS: Monitoring for
serotonergic adverse events should be done when oxycodone is
given to patients receiving serotonin-reuptake inhibitors.
Record Date Created: 20060106
Record Date Completed: 20060410
Date of Electronic Publication: 20051220 |
RELATED HOW DO I...? SOLUTIONS
NEED HELP?
Contact the Dialog Knowledge Center
Within North America 1 800 3 DIALOG (334 2564)
Outside North America 0 800 33 DIALOG (33 34 2564)
Web Form www.dialog.com/contacts/webform

|

You are viewing the

Click below to view the
 |